We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
-20.47%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$9.64B
AUM Growth
-$2.48B
Cap. Flow
+$636M
Cap. Flow %
6.6%
Top 10 Hldgs %
42.18%
Holding
1,253
New
58
Increased
575
Reduced
265
Closed
42

Sector Composition

Rank Sector Weight
1 Real Estate 70.9%
2 Technology 5.34%
3 Financials 3.16%
4 Healthcare 3.13%
5 Industrials 2.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RUBY
1151
DELISTED
Rubius Therapeutics, Inc
RUBY
$2K ﹤0.01%
450
FLXN
1152
DELISTED
Flexion Therapeutics, Inc.
FLXN
$2K ﹤0.01%
215
PRVL
1153
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
$2K ﹤0.01%
192
PGNX
1154
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$2K ﹤0.01%
533
PDLI
1155
DELISTED
PDL BioPharma, Inc.
PDLI
$2K ﹤0.01%
644
BDSI
1156
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$2K ﹤0.01%
507
ADMA icon
1157
ADMA Biologics
ADMA
$2.02B
$1K ﹤0.01%
335
AFMD
1158
DELISTED
Affimed
AFMD
$1K ﹤0.01%
+43
New +$1.02K
AUTL
1159
Autolus Therapeutics
AUTL
$389M
$1K ﹤0.01%
168
CLLS
1160
Cellectis
CLLS
$288M
$1K ﹤0.01%
100
DBC icon
1161
Invesco DB Commodity Index Tracking Fund
DBC
$1.69B
$1K ﹤0.01%
100
-400
-80% -$5.59K
DNTH icon
1162
Dianthus Therapeutics
DNTH
$5.69B
$1K ﹤0.01%
14
EOLS icon
1163
Evolus
EOLS
$397M
$1K ﹤0.01%
173
EYPT icon
1164
EyePoint Inc
EYPT
$999M
$1K ﹤0.01%
62
GERN icon
1165
Geron
GERN
$898M
$1K ﹤0.01%
880
CBIO
1166
Crescent Biopharma
CBIO
$546M
$1K ﹤0.01%
3
LXRX icon
1167
Lexicon Pharmaceuticals
LXRX
$1.03B
$1K ﹤0.01%
583
MNKD icon
1168
MannKind Corp
MNKD
$1.19B
$1K ﹤0.01%
1,042
OPTN
1169
DELISTED
OptiNose
OPTN
$1K ﹤0.01%
18
PRQR icon
1170
ProQR Therapeutics
PRQR
$244M
$1K ﹤0.01%
246
PSNL icon
1171
Personalis
PSNL
$1.25B
$1K ﹤0.01%
176
PTGX icon
1172
Protagonist Therapeutics
PTGX
$8.55B
$1K ﹤0.01%
154
RIGL icon
1173
Rigel Pharmaceuticals
RIGL
$723M
$1K ﹤0.01%
81
SLDB icon
1174
Solid Biosciences
SLDB
$792M
$1K ﹤0.01%
20
SYRE icon
1175
Spyre Therapeutics
SYRE
$8.5B
$1K ﹤0.01%
6

Similar funds

Daiwa Securities Group's Q1 2020 Portfolio in Review

As of Q1 2020, Daiwa Securities Group held 1,253 positions worth $9.64B, down 20% from $12.1B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Daiwa Securities Group deployed $636M of net new capital in Q1 2020, opening 58 new positions and adding to 575 existing holdings. Its largest new stake was Global X Conscious Companies ETF: 6,650,000 shares worth $122M.

By sector, the portfolio is most concentrated in Real Estate at 71% of assets, down from 73% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Realty Income, an estimated $178M trimmed.

  • Daiwa Securities Group's largest Q1 2020 buy was Global X Conscious Companies ETF: 6,650,000 shares worth $122M.
  • Daiwa Securities Group added most to Public Storage in Q1 2020, an estimated $250M increase.
  • Daiwa Securities Group's biggest Q1 2020 reduction was Realty Income, cutting an estimated $178M.
  • Daiwa Securities Group fully exited RTX Corp in Q1 2020, selling an estimated $10.1M.
  • Daiwa Securities Group's ten largest holdings make up 42% of its $9.64B portfolio in Q1 2020.
  • Daiwa Securities Group opened 58 new positions and closed 42 in Q1 2020.
  • Daiwa Securities Group's portfolio value fell 20% quarter-over-quarter to $9.64B.

Based on Daiwa Securities Group's 13F filing for Q1 2020, filed 14 May 2020.